Prestige Consumer Healthcare (PBH) Total Debt (2011 - 2024)
Prestige Consumer Healthcare (PBH) recorded quarterly Total Debt of $1.1 billion in Q1 2024, down 16.35% quarter-over-quarter from $1.3 billion in Q1 2023, and down 16.35% on a YoY basis from $1.3 billion in Q2 2023.
Prestige Consumer Healthcare (PBH) Total Debt (2011 - 2024) Analysis & Trends
Prestige Consumer Healthcare's Total Debt history runs 14 years deep, the most recent figure standing at $1.1 billion for Q1 2024.
- In Q1 2024, Total Debt fell 16.35% year-over-year to $1.1 billion; the TTM figure through Mar 2024 stood at $1.1 billion (down 16.35% YoY), while the FY2024 annual figure was $1.1 billion, down 16.35% from the prior year.
- Total Debt was $1.1 billion for Q1 2024 at Prestige Consumer Healthcare, down from $1.3 billion in the prior quarter.
- In the past five years, Total Debt ranged from a high of $1.7 billion in Q1 2020 to a low of $6.0 million in Q3 2021.
- Historically, Total Debt has averaged $1.3 billion across 5 years, with a median of $1.5 billion in 2021.
- The sharpest annual moves came in 2021 and 2022: Total Debt tumbled 99.61% in 2021, then declined 0.2% in 2022.
- A 5-year view of Total Debt shows it stood at $1.5 billion in 2020, then tumbled by 99.61% to $6.0 million in 2021, then jumped by 24510.97% to $1.5 billion in 2022, then fell by 8.86% to $1.3 billion in 2023, then decreased by 16.35% to $1.1 billion in 2024.
- The last three Total Debt figures came in at $1.1 billion (Q1 2024), $1.3 billion (Q1 2023), and $1.5 billion (Q1 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 16.63 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 9.05 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 3.53 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 3.99 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.51 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 570.41 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Prestige Consumer Healthcare | 2.33 Bn | 2.26 Bn | 157.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 1.13 Bn |
| Mar 31, 2023 | 1.35 Bn |
| Mar 31, 2022 | 1.48 Bn |
| Sep 30, 2021 | 6.00 Mn |
| Jun 30, 2021 | 1.55 Bn |
| Mar 31, 2021 | 1.48 Bn |
| Dec 31, 2020 | 1.55 Bn |
| Sep 30, 2020 | 1.55 Bn |
| Jun 30, 2020 | 1.62 Bn |
| Mar 31, 2020 | 1.73 Bn |
| Dec 31, 2019 | 1.70 Bn |
| Sep 30, 2019 | 1.75 Bn |
| Jun 30, 2019 | 1.78 Bn |
| Mar 31, 2019 | 1.80 Bn |
| Dec 31, 2018 | 1.84 Bn |
| Sep 30, 2018 | 1.90 Bn |
| Jun 30, 2018 | 1.99 Bn |
| Mar 31, 2018 | 1.99 Bn |
| Dec 31, 2017 | 2.05 Bn |
| Sep 30, 2017 | 2.09 Bn |